Larvol Delta - A-Study-of-Emavusertib--An-Approved-Bruton-Tyrosine-Kinase-Inhibitor-BTKi-in-Participants-With-Chronic-Lymphocytic-Leukemia-CLL-and-Other-Bcell-Malignancies

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Brukinsa (zanubrutinib) - BeOne Medicines

http://clinicaltrials.gov/ct2/show/NCT07271667

Feb 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next